Neoadjuvant treatment of colorectal liver metastases is associated with altered contrast enhancement on computed tomography

Cancer Imaging

Volumn 11, Issue 1, 2011, Pages 91-99

  Bethke, Anne ^a   Kühne, Katrin ^a   Platzek, Ivan ^a   Stroszczynski, Christian ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

Colorectal carcinoma; Computed tomography; Liver; Neoadjuvant therapy

Indexed keywords

CETUXIMAB; FOLINIC ACID; IRINOTECAN; OXALIPLATIN;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CLINICAL ARTICLE; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; EUROPE; FEMALE; HUMAN; LIVER METASTASIS; LIVER PARENCHYMA; MALE; OPEN STUDY; PHASE 2 CLINICAL TRIAL (TOPIC); PORTAL VEIN; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMIC THERAPY; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CAMPTOTHECIN; COLORECTAL NEOPLASMS; FEMALE; FLUOROURACIL; HUMANS; LEUCOVORIN; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; ORGANOPLATINUM COMPOUNDS; RADIOGRAPHIC IMAGE ENHANCEMENT; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 79960481965     PISSN: None     EISSN: 14707330     Source Type: Journal    
DOI: 10.1102/1470-7330.2011.0015     Document Type: Article

References (28)

1. Leonard GD, Brenner B, Kemeny NE. Neoadjuvant chemotherapy before liver resection for patients with unresectable liver metastases from colorectal carcinoma. J Clin Oncol 2005; 23: 2038-48. doi:10.1200/JCO.2005.00.349. (Pubitemid 46211384)
2. Aloia TA, Sebagh M, Plasse M, et al. Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases. J Clin Oncol 2006; 24: 4983-90. doi:10.1200/JCO.2006.05.8156. (Pubitemid 46631400)
3. Weber T, Link KH. Radikale Chirurgie bei primaer metastasierten kolorektalen Karzinomen. Chir Gastroenterol 2007; 23: 360-6. doi:10.1159/000110482. (Pubitemid 351185617)
4. Benoist S, Nordlinger B. Neoadjuvant treatment before resection of liver metastases. Eur J Surg Oncol 2007; 33: 35-41.
5. Mahtani RL, Macdonald JS. Synergy between cetuximab and chemotherapy in tumors of the gastrointestinal tract. Oncologist 2008; 13: 39-50. doi:10.1634/theoncologist.2006-0049. (Pubitemid 351206695)
6. Tabernero J, Van Cutsem E, Diaz-Rubio E, et al. Phase II trial of cetuximab in combination with fluorouracil, leucovorin and oxaliplatin in the first-line treatment of metastatic colorectal cancer. J Clin Oncol 2007; 25: 5225-32. doi:10.1200/JCO.2007.13.2183. (Pubitemid 350232254)
7. Fernandez FG, Ritter J, Goodwin JW, Linehan DC, Hawkins WG, Strasberg SM. Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases. J Am Coll Surg 2005; 200: 845-53. doi:10.1016/j.jamcollsurg.2005.01.024. (Pubitemid 40744790)
8. Vauthey JN, Pawlik TM, Ribero D, et al. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol 2006; 24: 2065-72. doi:10.1200/JCO.2005.05. 3074. (Pubitemid 46622116)
9. Bydder GM, Chapman RW, Harry D, Bassan L, Sherlock S, Kreel L. Computed tomography attenuation values in fatty liver. J Comput Tomogr 1981; 5: 33-5. doi:10.1016/0149-936X(81)90054-0. (Pubitemid 11075771)
10. Kulemann V, Schima W, Tamandl D, et al. Preoperative detection of colorectal liver metastases in fatty liver: MDCT or MRI? Eur J Radiol 2010; doi:10.1016/j.ejrad.2010.03.004.
11. Kodama Y, Ng CS, Wu TT, et al. Comparison of ct methods for determining the fat content of the liver. Am J Roentgenol 2007; 188: 1307-12. doi:10.2214/AJR.06.0992. (Pubitemid 46668513)
12. Ong KO, Leen E. Radiological staging of colorectal liver metastases. Surg Oncol 2007; 16: 7-14. doi:10.1016/j.suronc.2007.04.001. (Pubitemid 46880336)
13. Sheafor DH, Frederick MG, Paulson EK, et al. Comparison of unenhanced, hepatic arterial-dominant, and portal venous-dominant phase helical CT for the detection of liver metastases in women with breast carcinoma. Am J Roentgenol 1999; 172: 961-8. (Pubitemid 29505621)
14. Aloysius MM, Zaitoun AM, Beckingham IJ, et al. The pathological response to neoadjuvant chemotherapy with Folfox-4 for colorectal liver metastases: a comparative study. Virchows Arch 2007; 451: 943-8. doi:10.1007/s00428-007-0497- 1. (Pubitemid 350060742)
15. Pawlik TM, Olino K, Gleisner AL, et al. Preoperative chemotherapy for colorectal liver metastases: Impact on hepatic histology and postoperative outcome. J Gastrointest Surg 2007; 11: 860-8. doi:10.1007/s11605-007-0149-4.
16. Bilchik AJ, Poston G, Curley SA, et al. Neoadjuvant chemotherapy for metastatic colon cancer: a cautionary note. J Clin Oncol 2005; 23: 9073-8. doi:10.1200/JCO.2005.03.2334.
17. Karoui M, Penna C, Amin-Hashem M, et al. Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases. Ann Surg 2006; 243: 1-7. doi:10.1097/01.sla.0000193603.26265.c3. (Pubitemid 43054046)
18. Rubbia-Brandt L, Audard V, Sartoretti P, et al. Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Ann Oncol 2004; 15: 460-6. doi:10.1093/annonc/ mdh095. (Pubitemid 38444550)
19. Kruskal JB, Thomas P, Kane RA, Goldberg SN. Hepatic perfusion changes in mice livers with developing colorectal cancer metastases. Radiology 2004; 231: 482-90. doi:10.1148/radiol.2312030160. (Pubitemid 38552908)
20. Leggett DA, Kelley BB, Bunce IH, Miles KA. Colorectal cancer: diagnostic potential of CT measurements of hepatic perfusion and implications for contrast enhancement protocols. Radiology 1997; 205: 716-20. (Pubitemid 27516706)
21. Miles KA, Young H, Chica SL, Esser PD. Quantitative contrast-enhanced computed tomography: is there a need for system calibration? Eur Radiol 2007; 17: 919-26. doi:10.1007/s00330-006-0424-x.
22. Kondo H, Kanematsu M, Goshima S, et al. Abdominal multidetector CT in patients with varying body fat percentages: estimation of optimal contrast material dose. Radiology 2008; 249: 872-7. doi:10.1148/radiol.2492080033.
23. Raptopoulos V, Karellas A, Bernstein J, Reale FR, Constantinou C, Zawacki JK. Value of dual-energy CT in differentiating focal fatty infiltration of the liver from low- density masses. Am J Roentgenol 1991; 157: 721-5.
24. Li Y, Zhang R, Liang BL, Yuan JP, Ye RX, Zhong JL. Types of liver metastases on MR imaging and characteristics of uncommon types. Chin J Cancer 2006; 25: 212-16.
25. Ng JK, Urbanski SJ, Mangat N, et al. Colorectal liver metastases contract centripetally with a response to chemotherapy: a histomorphologic study. Cancer 2008; 112: 362-71. doi:10.1002/cncr.23184.
26. Scott J, Guthrie A, Arnold P, et al. Dual phase helical ct versus portal venous phase CT for the detection of colorectal liver metastases: Correlation with intra-operative sonography, surgical and pathological findings. Clin Radiol 2001; 56: 235-42. doi:10.1053/crad.2000.0668.
27. Benoist S, Brouquet A, Penna C, et al. Complete response of colorectal liver metastases after chemotherapy: Does it mean cure? J Clin Oncol 2006; 24: 3939-45. doi:10.1200/JCO.2006.05.8727. (Pubitemid 46630742)
28. Van Vledder MG, de Jong MC, Pawlik TM, Schulick RD, Diaz LA, Choti MA. Disappearing colorectal liver metastases after chemotherapy: should we be concerned? J Gastrointest Surg 2010; 14: 1691-700/. doi:10.1007/s11605-010-1348- y.